TxGemma introduces a suite of efficient large language models specifically designed to address the high costs and failure rates in therapeutic development.

Key Innovations:

• Generalist LLM Architecture: Combines therapeutic property prediction with interactive reasoning and explainability
• Multi-scale Approach: Offers 2B, 9B, and 27B parameter versions for different computational needs
• Broad Application Scope: Synthesizes information from diverse sources to support multiple stages of the drug development pipeline
• Human-AI Collaboration: Enables interactive reasoning that complements human expertise

Business Impact: By integrating AI-driven insights across the therapeutic development process, TxGemma has the potential to significantly reduce costs, accelerate timelines, and improve success rates in an industry where failures cost billions.

TxGemma: Efficient and Agentic LLMs for Therapeutics